4D Molecular Therapeutics, Inc. Banner Image

4D Molecular Therapeutics, Inc.

  • Ticker FDMT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
4D Molecular Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Emeryville, California
4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Their vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences toMore invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Their product design, development and manufacturing engine empowers them to efficiently create their valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. They have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.
3.0 / 5.0 (3)

4D Molecular Therapeutics, Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

4D Molecular Therapeutics, Inc.

Most Recent Annual Report

4D Molecular Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

4D Molecular Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!